Hikma Opens Discussions To Acquire GSK OTC, Rx Businesses In Egypt, Tunisia
Deal Would Include Hikma Acquiring GSK’s 91.2% Holding
Executive Summary
With operations in the MENA region already tracking to $700m in revenues for 2020, Hikma is looking to grow the business further after beginning negotiations with GSK to buy certain of the originator’s businesses in Egypt and Tunisia.